Reinventing clinical trials.
Malorye
M
Allison
D017322:Clinical Trials, Phase II as Topic / Q000191:economics / Q000592:standards / Q000639:trends*; D017326:Clinical Trials, Phase III as Topic / Q000191:economics / Q000592:standards / Q000639:trends*; D017277:Drug Approval / Q000706:statistics & numerical data*; D004345:Drug Industry; D004526:Efficiency; D001330:Electronic Data Processing / Q000379:methods*; D006801:Humans; D054547:National Cancer Institute (U.S.); D012449:Safety / Q000592:standards; D013678:Technology, Pharmaceutical / Q000191:economics / Q000639:trends; D014481:United States; D014486:United States Food and Drug Administration